BioLineRx Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on August 19, 2024, by BioLineRx Ltd., a foreign private issuer, serves as a notification regarding corporate governance events rather than a financial report. The filing announces the scheduling of the company's Annual Meeting of Shareholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice and does not contain financial statements or performance data.
Material Changes
No material changes to financial performance or operations are reported in this filing. The primary update is the confirmation of the upcoming shareholder meeting date and location.
Guidance, Outlook, and Management Commentary
Management has announced that the Annual Meeting of Shareholders will be held on October 1, 2024, at 3:00 p.m. Israel time. The meeting will take place at the company's principal executive offices in Modi'in, Israel. The Notice of Annual General Meeting, Proxy Statement, and voting forms are attached as exhibits to this filing.
Key Facts for Investor Verification
- Meeting Date: October 1, 2024.
- Meeting Time: 3:00 p.m. Israel time.
- Location: BioLineRx Ltd. offices, Modi'in Technology Park, Israel.
- Documentation: Proxy materials are available as Exhibits 99.1, 99.2, and 99.3.
- Financial Data: None included in this specific filing; investors should refer to the most recent Form 20-F for financial results.